Back to Search
Start Over
Deciphering roles of TRIMs as promising targets in hepatocellular carcinoma: current advances and future directions.
- Source :
-
Biomedicine & Pharmacotherapy . Nov2023, Vol. 167, pN.PAG-N.PAG. 1p. - Publication Year :
- 2023
-
Abstract
- Tripartite motif (TRIM) family is assigned to RING-finger-containing ligases harboring the largest number of proteins in E3 ubiquitin ligating enzymes. E3 ubiquitin ligases target the specific substrate for proteasomal degradation via the ubiquitin–proteasome system (UPS), which seems to be a more effective and direct strategy for tumor therapy. Recent advances have demonstrated that TRIM genes associate with the occurrence and progression of hepatocellular carcinoma (HCC). TRIMs trigger or inhibit multiple biological activities like proliferation, apoptosis, metastasis, ferroptosis and autophagy in HCC dependent on its highly conserved yet diverse structures. Remarkably, autophagy is another proteolytic pathway for intracellular protein degradation and TRIM proteins may help to delineate the interaction between the two proteolytic systems. In depth research on the precise molecular mechanisms of TRIM family will allow for targeting TRIM in HCC treatment. We also highlight several potential directions warranted further development associated with TRIM family to provide bright insight into its translational values in hepatocellular carcinoma. [Display omitted] • TRIMs belong to RING-type E3 ligases with highly conserved but diverse structures. • TRIMs generally exert functions dependent on the ubiquitin–proteasome system. • TRIMs modulate ferroptosis and autophagy. • Various molecular players are involved in HCC regulation interacting with TRIMs. • TRIMs may be a potential target in HCC based on many perspectives. [ABSTRACT FROM AUTHOR]
- Subjects :
- *TRIM proteins
*UBIQUITIN ligases
*PROTEOLYSIS
*LIGASES
*UBIQUITIN
Subjects
Details
- Language :
- English
- ISSN :
- 07533322
- Volume :
- 167
- Database :
- Academic Search Index
- Journal :
- Biomedicine & Pharmacotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 172976523
- Full Text :
- https://doi.org/10.1016/j.biopha.2023.115538